<SEC-DOCUMENT>0001599298-25-000025-index.html : 20250106 <SEC-HEADER>0001599298-25-000025.hdr.sgml : 20250106 <ACCEPTANCE-DATETIME>20250106191122 ACCESSION NUMBER: 0001599298-25-000025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20250102 FILED AS OF DATE: 20250106 DATE AS OF CHANGE: 20250106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ronaghi Mostafa CENTRAL INDEX KEY: 0001441876 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36866 FILM NUMBER: 25512943 MAIL ADDRESS: STREET 1: 9885 TOWNE CENTRE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Summit Therapeutics Inc. CENTRAL INDEX KEY: 0001599298 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 371979717 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 601 BRICKELL KEY DRIVE STREET 2: SUITE 1000 CITY: MIAMI STATE: FL ZIP: 33131 BUSINESS PHONE: 305-203-2034 MAIL ADDRESS: STREET 1: 601 BRICKELL KEY DRIVE STREET 2: SUITE 1000 CITY: MIAMI STATE: FL ZIP: 33131 FORMER COMPANY: FORMER CONFORMED NAME: Summit Therapeutics plc DATE OF NAME CHANGE: 20150219 FORMER COMPANY: FORMER CONFORMED NAME: Summit Corp plc DATE OF NAME CHANGE: 20140205 </SEC-HEADER> <DOCUMENT> <TYPE>4 <SEQUENCE>1 <FILENAME>wk-form4_1736208674.xml <DESCRIPTION>FORM 4 <TEXT> Document 1 - file: wk-form4_1736208674.html
Document 1 - RAW XML: wk-form4_1736208674.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-24 <SEQUENCE>2 <FILENAME>poasec16-mostafaronaghif.htm <DESCRIPTION>EX-24 <TEXT> Document 2 - file: poasec16-mostafaronaghif.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>poasec16-mostafaronaghif001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: poasec16-mostafaronaghif001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>poasec16-mostafaronaghif002.jpg <TEXT> Document 4 - file: poasec16-mostafaronaghif002.jpg
</DOCUMENT> </SEC-DOCUMENT>